Cargando…

Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Aberrations in DNA methylation profiles may alter the expression of key miRNAs in non-small cell lung cancer. In this study, we focus on the analysis of the imprinted C19MC and MIR371-3 miRNA clusters due to their oncogenic role. We identified the DNA methylation status and discovere...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyero, Laura, Noguera-Uclés, José Francisco, Castillo-Peña, Alejandro, Salinas, Ana, Sánchez-Gastaldo, Amparo, Alonso, Miriam, Benedetti, Johana Cristina, Bernabé-Caro, Reyes, Paz-Ares, Luis, Molina-Pinelo, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000578/
https://www.ncbi.nlm.nih.gov/pubmed/36900258
http://dx.doi.org/10.3390/cancers15051466
_version_ 1784903912762900480
author Boyero, Laura
Noguera-Uclés, José Francisco
Castillo-Peña, Alejandro
Salinas, Ana
Sánchez-Gastaldo, Amparo
Alonso, Miriam
Benedetti, Johana Cristina
Bernabé-Caro, Reyes
Paz-Ares, Luis
Molina-Pinelo, Sonia
author_facet Boyero, Laura
Noguera-Uclés, José Francisco
Castillo-Peña, Alejandro
Salinas, Ana
Sánchez-Gastaldo, Amparo
Alonso, Miriam
Benedetti, Johana Cristina
Bernabé-Caro, Reyes
Paz-Ares, Luis
Molina-Pinelo, Sonia
author_sort Boyero, Laura
collection PubMed
description SIMPLE SUMMARY: Aberrations in DNA methylation profiles may alter the expression of key miRNAs in non-small cell lung cancer. In this study, we focus on the analysis of the imprinted C19MC and MIR371-3 miRNA clusters due to their oncogenic role. We identified the DNA methylation status and discovered its deregulated target genes in this disease. Additionally, we found five downstream target genes that were correlated with worse overall survival in non-small cell lung cancer. We conclude that C19MC and MIR371-3 are key players in lung cancer because their polycistronic epigenetic regulation leads to differential tumor expression, affecting downstream targets with prognostic value. ABSTRACT: Epigenetic mechanisms have emerged as an important contributor to tumor development through the modulation of gene expression. Our objective was to identify the methylation profile of the imprinted C19MC and MIR371-3 clusters in patients with non-small cell lung cancer (NSCLC) and to find their potential target genes, as well as to study their prognostic role. DNA methylation status was analyzed in a NSCLC patient cohort (n = 47) and compared with a control cohort including COPD patients and non-COPD subjects (n = 23) using the Illumina Infinium Human Methylation 450 BeadChip. Hypomethylation of miRNAs located on chromosome 19q13.42 was found to be specific for tumor tissue. We then identified the target mRNA–miRNA regulatory network for the components of the C19MC and MIR371-3 clusters using the miRTargetLink 2.0 Human tool. The correlations of miRNA-target mRNA expression from primary lung tumors were analyzed using the CancerMIRNome tool. From those negative correlations identified, we found that a lower expression of 5 of the target genes (FOXF2, KLF13, MICA, TCEAL1 and TGFBR2) was significantly associated with poor overall survival. Taken together, this study demonstrates that the imprinted C19MC and MIR371-3 miRNA clusters undergo polycistronic epigenetic regulation leading to deregulation of important and common target genes with potential prognostic value in lung cancer.
format Online
Article
Text
id pubmed-10000578
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100005782023-03-11 Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer Boyero, Laura Noguera-Uclés, José Francisco Castillo-Peña, Alejandro Salinas, Ana Sánchez-Gastaldo, Amparo Alonso, Miriam Benedetti, Johana Cristina Bernabé-Caro, Reyes Paz-Ares, Luis Molina-Pinelo, Sonia Cancers (Basel) Article SIMPLE SUMMARY: Aberrations in DNA methylation profiles may alter the expression of key miRNAs in non-small cell lung cancer. In this study, we focus on the analysis of the imprinted C19MC and MIR371-3 miRNA clusters due to their oncogenic role. We identified the DNA methylation status and discovered its deregulated target genes in this disease. Additionally, we found five downstream target genes that were correlated with worse overall survival in non-small cell lung cancer. We conclude that C19MC and MIR371-3 are key players in lung cancer because their polycistronic epigenetic regulation leads to differential tumor expression, affecting downstream targets with prognostic value. ABSTRACT: Epigenetic mechanisms have emerged as an important contributor to tumor development through the modulation of gene expression. Our objective was to identify the methylation profile of the imprinted C19MC and MIR371-3 clusters in patients with non-small cell lung cancer (NSCLC) and to find their potential target genes, as well as to study their prognostic role. DNA methylation status was analyzed in a NSCLC patient cohort (n = 47) and compared with a control cohort including COPD patients and non-COPD subjects (n = 23) using the Illumina Infinium Human Methylation 450 BeadChip. Hypomethylation of miRNAs located on chromosome 19q13.42 was found to be specific for tumor tissue. We then identified the target mRNA–miRNA regulatory network for the components of the C19MC and MIR371-3 clusters using the miRTargetLink 2.0 Human tool. The correlations of miRNA-target mRNA expression from primary lung tumors were analyzed using the CancerMIRNome tool. From those negative correlations identified, we found that a lower expression of 5 of the target genes (FOXF2, KLF13, MICA, TCEAL1 and TGFBR2) was significantly associated with poor overall survival. Taken together, this study demonstrates that the imprinted C19MC and MIR371-3 miRNA clusters undergo polycistronic epigenetic regulation leading to deregulation of important and common target genes with potential prognostic value in lung cancer. MDPI 2023-02-25 /pmc/articles/PMC10000578/ /pubmed/36900258 http://dx.doi.org/10.3390/cancers15051466 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boyero, Laura
Noguera-Uclés, José Francisco
Castillo-Peña, Alejandro
Salinas, Ana
Sánchez-Gastaldo, Amparo
Alonso, Miriam
Benedetti, Johana Cristina
Bernabé-Caro, Reyes
Paz-Ares, Luis
Molina-Pinelo, Sonia
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
title Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
title_full Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
title_fullStr Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
title_full_unstemmed Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
title_short Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
title_sort aberrant methylation of the imprinted c19mc and mir371-3 clusters in patients with non-small cell lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000578/
https://www.ncbi.nlm.nih.gov/pubmed/36900258
http://dx.doi.org/10.3390/cancers15051466
work_keys_str_mv AT boyerolaura aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT noguerauclesjosefrancisco aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT castillopenaalejandro aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT salinasana aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT sanchezgastaldoamparo aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT alonsomiriam aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT benedettijohanacristina aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT bernabecaroreyes aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT pazaresluis aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer
AT molinapinelosonia aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer